Company: LRHC
Filing Date: 2025-08-08
Form Type: PRE 14C
Source: 0001213900-25-073694
Chunk: 5

Company: La Rosa Holdings Corp.
Filing Date: 2025-08-08
Form: PRE 14C
Chunk 5
---
 will reimburse such
persons for out-of-pocket expenses incurred in forwarding such material.

<div align='center'>WE ARE NOT ASKING YOU FOR A PROXY, AND

YOU ARE REQUESTED NOT TO SEND US A PROXY.

2

ACTION TAKEN</div>

This Information Statement contains a brief summary of the material
aspects of the Corporate Action approved by the Majority Stockholders.

1. APPROVAL OF ISSUANCE OF SHARES OF COMMON STOCK PURSUANT TO THE FACILITY IN EXCESS OF 19.99% OF THE ISSUED AND OUTSTANDING COMMON STOCK IN COMPLIANCE WITH NASDAQ’S 20% RULE

On August 4, 2025 (the “Agreement Date”), the Company entered
into the Equity Purchase Facility Agreement (“Facility Agreement”) with SZOP Opportunities I LLC, a Delaware limited
liability company (the “Investor”), pursuant to which the Investor committed to purchase, subject to certain conditions and
limitations, up to $150,000,000 (the “Commitment Amount”) in newly issued shares of the Common Stock (the “Facility”).
In connection with the Facility, on the Agreement Date the Company also entered into a Registration Rights Agreement (the “RRA”)
with the Investor.

Pursuant to the terms of the Facility Agreement, the issuance of shares
of Common Stock in excess of 19.99% of the Company’s outstanding shares of Common Stock is conditional upon obtaining the approval
of the Company’s stockholders in accordance with the rules and regulations of the Nasdaq Capital Market.

Pursuant to the Facility
Agreement, the Company is required to provide each stockholder entitled to vote at a meeting of stockholders of the Company (the
“Stockholder Meeting”), which shall be promptly called and held not later than sixty (60) days after the Agreement Date
(the “Stockholder Meeting Deadline”), a proxy statement in a form reasonably acceptable to the Investor and counsel, at
the expense of the Company to solicit each of the Company’s stockholders’ affirmative vote at the Stockholder Meeting
for approval of the proposal (“Stockholder Proposal”) to authorize the issuance of all of the shares of Common Stock
issuable thereunder in compliance with the rules and regulations of the Nasdaq Capital Market (such affirmative approval being
referred to herein as the “Stockholder Approval”, and the date such Stockholder Approval is obtained, the
“Stockholder Approval Date”), and the Company is required to use its reasonable